AstraZeneca Slashes 700 Jobs In The US


AstraZeneca, which is based in the UK, has a significant presence in the United States. But it will be cutting down on those numbers in a major way. AstraZeneca announced that it will be cutting 700 jobs in the United States in an effort to “transform its commercial business as part of the company’s return to growth strategy.” AstraZeneca has faced the loss of patent exclusivity on several drugs, which could be contributing to the downsizing in the US.

Read the source article at

About the Author

Related Posts

Leave a Reply